These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Protein carbamylation predicts mortality in ESRD. Koeth RA; Kalantar-Zadeh K; Wang Z; Fu X; Tang WH; Hazen SL J Am Soc Nephrol; 2013 Apr; 24(5):853-61. PubMed ID: 23431074 [TBL] [Abstract][Full Text] [Related]
4. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure. Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction. Tang WH; Shrestha K; Tong W; Wang Z; Troughton RW; Borowski AG; Klein AL; Hazen SL Transl Res; 2013 Jul; 162(1):26-33. PubMed ID: 23499315 [TBL] [Abstract][Full Text] [Related]
6. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure. Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Tang WH; Shrestha K; Shao Z; Borowski AG; Troughton RW; Thomas JD; Klein AL Am J Cardiol; 2011 Aug; 108(3):385-90. PubMed ID: 21600537 [TBL] [Abstract][Full Text] [Related]
8. Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. Tang WH; Van Lente F; Shrestha K; Troughton RW; Francis GS; Tong W; Martin MG; Borowski AG; Jasper S; Starling RC; Klein AL J Card Fail; 2008 Jun; 14(5):394-9. PubMed ID: 18514931 [TBL] [Abstract][Full Text] [Related]
9. Effects of ivabradine therapy on heart failure biomarkers. Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317 [TBL] [Abstract][Full Text] [Related]
10. Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure. Shrestha K; Borowski AG; Troughton RW; Thomas JD; Klein AL; Tang WH J Card Fail; 2011 Jun; 17(6):472-8. PubMed ID: 21624735 [TBL] [Abstract][Full Text] [Related]
11. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. Tang WH; Shrestha K; Wang Z; Troughton RW; Klein AL; Hazen SL J Card Fail; 2013 Feb; 19(2):87-93. PubMed ID: 23384633 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: a long term follow-up study. Bosselmann H; Egstrup M; Rossing K; Gustafsson I; Gustafsson F; Tonder N; Kistorp CN; Goetze JP; Schou M Int J Cardiol; 2013 Dec; 170(2):202-7. PubMed ID: 24182673 [TBL] [Abstract][Full Text] [Related]
13. Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study. Bosselmann H; Tonder N; Sölétormos G; Rossing K; Iversen K; Goetze JP; Gustafsson F; Schou M Int J Cardiol; 2014 Dec; 177(3):942-8. PubMed ID: 25449505 [TBL] [Abstract][Full Text] [Related]
14. Right atrial volume index in chronic systolic heart failure and prognosis. Sallach JA; Tang WH; Borowski AG; Tong W; Porter T; Martin MG; Jasper SE; Shrestha K; Troughton RW; Klein AL JACC Cardiovasc Imaging; 2009 May; 2(5):527-34. PubMed ID: 19442936 [TBL] [Abstract][Full Text] [Related]
15. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. Tang WH; Tong W; Troughton RW; Martin MG; Shrestha K; Borowski A; Jasper S; Hazen SL; Klein AL J Am Coll Cardiol; 2007 Jun; 49(24):2364-70. PubMed ID: 17572253 [TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure. Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846 [TBL] [Abstract][Full Text] [Related]
18. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
19. Prognostic utility of the Seattle Heart Failure Score and amino terminal pro B-type natriuretic peptide in varying stages of systolic heart failure. Adlbrecht C; Hülsmann M; Neuhold S; Strunk G; Pacher R J Heart Lung Transplant; 2013 May; 32(5):533-8. PubMed ID: 23453573 [TBL] [Abstract][Full Text] [Related]
20. Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure. Gaborit F; Bosselmann H; Tønder N; Iversen K; Kümler T; Kistorp C; Sölétormos G; Goetze JP; Schou M BMC Cardiovasc Disord; 2015 Aug; 15():92. PubMed ID: 26289429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]